A CEO of a gene-editing firm is scheduled to speak…
A prominent gene-editing company has announced that its CEO will deliver a keynote address in London on November 16. This event is anticipated to draw significant attention from industry professionals, researchers, and stakeholders interested in the advancements and ethical considerations
